Wilmington, DECIK 8970704 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
109 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Globalstar Inc | 999.0K | $60.98M | 6.8% | −410.3K | Reduced |
| 2 | Ligand Pharmaceuticals Inc | 213.8K | $40.42M | 4.5% | −30.7K | Reduced |
| 3 | Vicor Corp | 353.9K | $38.78M | 4.3% | +128.7K | Added |
| 4 | Red Violet Inc |
| 602.8K |
| $34.33M |
| 3.8% |
| +22.1K |
| Added |
| 5 | Vanguard Index Fds | 93.8K | $31.46M | 3.5% | +1.3K | Added |
| 6 | Supernus Pharmaceuticals Inc | 612.5K | $30.44M | 3.4% | +48.8K | Added |
| 7 | Cellebrite Di Ltd | 1.67M | $30.13M | 3.4% | −29.4K | Reduced |
| 8 | Stonex Group Inc | 298.3K | $28.38M | 3.2% | −14.9K | Reduced |
| 9 | Oddity Tech Ltd | 686.0K | $27.56M | 3.1% | +137.4K | Added |
| 10 | Healthequity Inc | 271.7K | $24.89M | 2.8% | −240 | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio